Royal Marsden Hospital, London
Description: In this study day I describe the unique cellular and genetic features of haematological cancers and cover a diverse range of targeted treatments for leukaemias, lymphomas and multiple myeloma. For each disease I explain the relevant treatments, including a wide range of monoclonal antibodies, bi-specifics and other antibody-based treatments, as well as B cell receptor signalling blockers, and inhibitors of Bcl-2 and FLT3. I explore the potential of immunotherapy with CAR T cells, focusing on ALL, NHL and myeloma.
Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
To book, contact: firstname.lastname@example.org or call: 020 7808 2922
View a PDF of the programme